Home  /  Resource Library  /  EHA 2019 | Results of the phase II LYMA-101 trial

EHA 2019 | Results of the phase II LYMA-101 trial

EHA 2019: Results of a phase II study investigating obinutuzumab in combination with chemotherapy followed by autologous stem cell transplant for first line treatment of mantle cell lymphoma.